MENU

COLL Stock Collegium Pharmaceutical (COLL, $34.37) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 28, 2024

A.I.dvisor
at Tickeron.com
05/29/24
Loading...
COLL - Collegium Pharmaceutical
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $34.37
Daily change: +$0.12 (+0.35%)
Daily volume: 352.4K
Capitalization: $1.1B
Industry: Pharmaceuticals: Other
This is a Bullish indicator signaling COLL's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 43 similar cases where COLL's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

COLL in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 13, 2024

COLL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where COLL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COLL advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 08, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on COLL as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

COLL moved below its 50-day moving average on October 21, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for COLL crossed bearishly below the 50-day moving average on October 23, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COLL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for COLL entered a downward trend on November 13, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.365) is normal, around the industry mean (57.359). P/E Ratio (30.171) is within average values for comparable stocks, (88.497). COLL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.877). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (2.869) is also within normal values, averaging (19.066).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Technology Center Drive
Phone
+1 781 713-3699
Employees
197
Web
https://www.collegiumpharma.com